Palo Alto, California – September 15, 2025 – Sciton, Inc., a leader in medical aesthetic laser and light-based technology, has introduced the HALO® TRIBRID™, the world’s first triple-wavelength resurfacing laser. This innovative device combines three independently controlled wavelengths—2940 nm, 1927 nm, and 1470 nm—into a single handpiece, offering a comprehensive solution for skin resurfacing. Designed to address a wide range of aesthetic concerns, HALO TRIBRID aims to deliver optimal outcomes in less time, enhancing both patient satisfaction and clinical efficiency.
Science Significance
The HALO TRIBRID™ integrates three award-winning technologies into one device, targeting multiple layers of the skin in a single session. The 2940 nm wavelength provides superficial ablation, improving skin texture and reducing imperfections. The 1927 nm wavelength targets pigmentation issues and enhances skin luminosity. The 1470 nm wavelength penetrates deeper dermal layers, promoting collagen remodeling and improving skin tone. This multi-layered approach allows for comprehensive treatment of various skin concerns, from fine lines and wrinkles to sun damage and uneven pigmentation. The ability to customize treatments based on individual patient needs makes HALO TRIBRID a groundbreaking tool in aesthetic care.
Regulatory Significance
As of September 15, 2025, HALO TRIBRID™ is a newly unveiled technology and has yet to receive specific regulatory approvals. However, Sciton’s commitment to patient safety and clinical excellence suggests that rigorous testing and evaluation will follow to meet safety and efficacy standards. The integration of multiple wavelengths into one device may streamline the approval process, provided that clinical data supports the benefits and safety of the treatment. This could encourage regulatory bodies to adapt guidelines that accommodate multifunctional medical devices while maintaining strict oversight.
Business Significance
Advertisement
The introduction of HALO TRIBRID™ positions Sciton at the forefront of the aesthetic laser industry. By consolidating three technologies into one device, Sciton offers practitioners a versatile tool that can address a broad spectrum of skin concerns, potentially increasing patient throughput and satisfaction. The device’s efficiency may lead to cost savings for clinics, enhancing their return on investment. Additionally, its comprehensive treatment capabilities could attract new clients and expand Sciton’s presence in the competitive field of medical aesthetics.
Patients’ Significance
For patients, HALO TRIBRID™ offers a treatment that addresses multiple skin concerns in one session. By combining different wavelengths, the device enables customized treatments tailored to individual skin types and conditions. Patients can expect improvements in skin texture, tone, and clarity with minimal downtime compared to traditional resurfacing methods. The deeper penetration offered by the 1470 nm wavelength helps boost collagen production, potentially resulting in longer-lasting results and higher satisfaction
Policy Significance
The launch of HALO TRIBRID™ highlights the need for updated policies that can accommodate advancements in medical technologies. As devices become more multifunctional, regulatory frameworks will need to ensure that safety, efficacy, and patient well-being remain at the forefront. Policymakers may also need to encourage innovation while balancing oversight to prevent misuse or premature adoption. The introduction of technologies like HALO TRIBRID™ could serve as a model for developing new guidelines that support both patient care and industry advancement.
The HALO TRIBRID™ represents a significant leap forward in the field of skin resurfacing. With its unique combination of wavelengths, it offers practitioners a powerful tool to treat a variety of skin concerns efficiently and effectively. As this new technology moves through clinical evaluation and regulatory pathways, it is set to redefine standards in aesthetic treatments. By providing enhanced outcomes and tailored care, HALO TRIBRID™ has the potential to transform how skin rejuvenation is approached around the world.
Source: Sciton, Inc. Press Release
